Misbah Tahir, Chief Financial Officer at IGM Biosciences, Inc. (IGMS), sold 877 shares at $21.99 ($19K) on 2022-11-23, disclosed to the SEC on 2022-11-28.
Open-market sale of $19k IGMS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.38 | 600 | $13K | 67.8% |
| 2 | $21.99 | 277 | $6K | 32.2% |
| Total | $21.57 avg | 877 | $19K | 100% |
| Filing → |
| IGMS | SELL | 2025-03-18 | $9K | — | Filing → |
| IGMS | SELL | 2024-12-18 | $13K | — | Filing → |
| IGMS | SELL | 2024-09-17 | $17K | — | Filing → |